XTANT MEDICAL HOLDINGS, INC. (XTNT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 3.72M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 7.29M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 79.67M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $3.72M | $7.29M | (m) | (m) | $79.67M | (m) |
| 2026-03-31 | (m) | (m) | $3.72M | $8.10M | (m) | (m) | $78.00M | (m) |
| 2025-12-31 | (m) | (m) | $3.50M | $11.03M | (m) | (m) | $94.14M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $17.40M | (m) | (m) | $106.32M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $22.28M | (m) | (m) | $103.48M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $22.17M | (m) | (m) | $95.83M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $22.04M | (m) | (m) | $93.84M | (m) |
| 2024-09-30 | (m) | (m) | $2.75M | $19.14M | (m) | (m) | $98.88M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $21.77M | (m) | (m) | $95.58M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $16.83M | (m) | (m) | $93.93M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $17.17M | (m) | (m) | $92.61M | (m) |
| 2023-09-30 | (m) | (m) | $2.83M | $14.35M | (m) | (m) | $92.00M | (m) |
| 2023-06-30 | (m) | (m) | $708.00K | $16.40M | (m) | (m) | $65.22M | (m) |
| 2023-03-31 | (m) | (m) | $4.72M | $12.32M | (m) | (m) | $63.32M | (m) |
| 2022-12-31 | (m) | (m) | $2.33M | $9.69M | (m) | (m) | $60.23M | (m) |
| 2022-09-30 | (m) | (m) | $1.33M | $10.63M | (m) | (m) | $56.05M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $11.90M | (m) | (m) | $52.71M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $11.84M | (m) | (m) | $53.17M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $11.79M | (m) | (m) | $54.69M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $11.68M | (m) | (m) | $55.79M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $11.68M | (m) | (m) | $59.68M | (m) |
| 2021-03-31 | (m) | (m) | $16.49M | (m) | (m) | (m) | $58.70M | (m) |
| 2020-12-31 | (m) | (m) | $16.80M | (m) | (m) | (m) | $41.47M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $79.63M | (m) | (m) | $42.39M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $77.53M | (m) | (m) | $41.67M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $77.34M | (m) | (m) | $42.55M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $76.24M | (m) | (m) | $43.16M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $74.98M | (m) | (m) | $43.04M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $73.83M | (m) | (m) | $44.50M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $72.66M | (m) | (m) | $47.06M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $77.94M | (m) | (m) | $46.42M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $75.94M | (m) | (m) | $99.27M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $79.43M | (m) | (m) | $102.78M | (m) |
| 2017-12-31 | (m) | (m) | (m) | $67.11M | (m) | (m) | $105.70M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $49.49M | (m) | (m) | $142.45M | (m) |
| 2016-06-30 | (m) | (m) | (m) | $46.66M | (m) | (m) | $141.31M | (m) |
| 2016-03-31 | (m) | (m) | (m) | $45.93M | (m) | (m) | $141.39M | (m) |
| 2015-12-31 | (m) | (m) | $0.00 | $44.70M | (m) | (m) | $143.06M | (m) |
| 2015-09-30 | (m) | (m) | $53.17K | $44.30M | (m) | (m) | $126.23M | (m) |
| 2015-06-30 | (m) | (m) | $52.37K | $21.69M | (m) | (m) | $26.35M | (m) |
| 2015-03-31 | (m) | (m) | $51.57K | $21.28M | (m) | (m) | $27.40M | (m) |
| 2014-12-31 | (m) | (m) | $50.67K | $20.87M | (m) | (m) | $27.95M | (m) |
| 2014-09-30 | (m) | (m) | $49.92K | $20.46M | (m) | (m) | $31.81M | (m) |
| 2014-06-30 | (m) | (m) | $49.18K | $20.05M | (m) | (m) | $28.42M | (m) |
| 2014-03-31 | (m) | (m) | $48.45K | $19.64M | (m) | (m) | $31.23M | (m) |
| 2013-12-31 | (m) | (m) | $47.73K | $16.39M | (m) | (m) | $28.88M | (m) |
| 2013-09-30 | (m) | (m) | $47.02K | $16.06M | (m) | (m) | $31.04M | (m) |
| 2013-06-30 | (m) | (m) | $46.32K | $15.34M | (m) | (m) | $35.12M | (m) |
| 2013-03-31 | (m) | (m) | $45.63K | $14.72M | (m) | (m) | $32.75M | (m) |
| 2012-12-31 | (m) | (m) | $45.13K | $14.48M | (m) | (m) | $34.50M | (m) |
| 2012-09-30 | (m) | (m) | $44.47K | $14.22M | (m) | (m) | $38.45M | (m) |
| 2012-06-30 | (m) | (m) | $4.26M | $6.36M | (m) | (m) | $28.45M | (m) |
| 2012-03-31 | (m) | (m) | $2.27M | $6.02M | (m) | (m) | $26.71M | (m) |
| 2011-12-31 | (m) | (m) | $1.63M | $6.64M | (m) | (m) | $23.17M | (m) |
| 2011-09-30 | (m) | (m) | $1.10M | $7.14M | (m) | (m) | $23.41M | (m) |
| 2011-06-30 | (m) | (m) | $907.11K | $4.28M | (m) | (m) | $19.75M | (m) |
| 2010-12-31 | (m) | (m) | $234.15K | $2.19M | (m) | (m) | $15.76M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |